EKSPERIMENTAL ALLOKSAN DIABETDA ASTAKSANTIN KOMPLEKSINING POSTENTERAL GIPERGLIKEMIYAGA TA’SIRI
##submission.downloads##
Qandli diabetda uglevod almashinuvining buzilishi muhim patogenetik omillardan biri bo‘lib, giperglikemiya sharoitida yuzaga
keluvchi oksidativ stress ichak epiteliysi funksional holatining o‘zgarishiga va glyukoza transportining ortishiga olib keladi. Shu
sababli kuchli antioksidant xususiyatga ega boʻlgan xavfsiz qoʻshimchalardan foydalanish orqali yalligʻlanish keltirib chiqaradigan
asoratlarning oldini olishi va diabetda metabolik buzilishlarni korreksiya qilishda istiqbolli yo‘nalish hisoblanadi.
Markur maqolada eksperimental diabetda astaksantin va selen mikroelementi kompleksi bilan korreksiyalashda ichakda glyukoza
so‘rilishiga ta’siri o‘rganildi.
Eksperimental diabetda kalamushlarni astaksantin bilan terapiyasi postenteral goperglikemiyani sezilarli darajada kamaytirmdi,
biroq astaksantin va selen kombinatsiyasi kasallangan hayvonlarning qonda glyukoza miqdorini pasayishi monopreparatdan ko‘ra
samaraliroq bo‘ldi.
Olingan natijalar astaksantin selen bilan kompleksi diabet kasalligini korrektsiyalashda samarali qoʻshimcha vosita sifatida
foydalanish mumkinligini tasdiqlaydi.
1. Karamanou M (2016). "Milestones in the history of diabetes mellitus: The main contributors". World Journal of Diabetes. 7
(1): 7. doi:10.4239/wjd.v7.i1.1. PMC 4707300. PMID 26788261
2. Ugolev A.M. Membrane digestion. Gut. 1972;13:735–747. doi: 10.1136/gut.13.9.735.
3. Guo L, Xu Y, Zhang X, Luo Y, Liu W, Chen B. Insulinization: a promising strategy for the treatment of type 2 diabetes
mellitus. Exp Ther Med. 2013;6:1300–1306. doi: 10.3892/etm.2013.1300.
4. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L. Ghrelin cells replace insulin-producing beta cells in two
mouse models of pancreas development. Proc Natl Acad Sci USA. 2004;101:2924–2929. doi: 10.1073/pnas.0308604100.
5. Kellett, G. L. Apical GLUT2 : A Major Pathway of Intestinal Sugar Absorption / G. L. Kellett, P. A. Helliwell. – Text :
electronic // Diabetes. – 2005. – Vol. 54, No. 10. – P. 3056–3062
6. Choi S.W., Ho C.K. Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound
or conceal effects of antioxidant therapy? Redox Rep. 2018;23:1–24. doi: 10.1080/13510002.2017.1324381
7. Urakaze M., Kobashi C., Kishimoto Y. The Beneficial Effects of Astaxanthin on Glucose Metabolism: A Review of the
Evidence // Nutrients. – 2021. – Vol. 13, № 12. – P. 4381.
Mulkiiyat (c) 2026 «O‘zMU XABARLARI»
Ushbu ish quyidagi litsenziya asosida ruxsatlangan Kreativ Commons Attribution-NonCommercial-ShareAlike 4.0 International litsenziyasi asosida bu ish ruxsatlangan..
.jpg)
.png)
